FDA Notices of Judgment Collection, 1908-1966

Search

Start Over Collections Drugs and Devices, 1940-1963 ✖Remove constraint Collections: Drugs and Devices, 1940-1963 Titles 3622. Misbranding of Dexedrine Sulfate tablets, Gantrisin tablets, and Seconal Sodium capsules. U. S. v. Gary Drug Co., Inc., Jacob H. Raverby, and Tobias Levine. Pleas of guilty. Fine of $200 against corporation and 50 against each individual. ✖Remove constraint Titles: 3622. Misbranding of Dexedrine Sulfate tablets, Gantrisin tablets, and Seconal Sodium capsules. U. S. v. Gary Drug Co., Inc., Jacob H. Raverby, and Tobias Levine. Pleas of guilty. Fine of $200 against corporation and 50 against each individual. Issue Dates May 1952 ✖Remove constraint Issue Dates: May 1952

Refine by:

  • 3622. Misbranding of Dexedrine Sulfate tablets, Gantrisin tablets, and Seconal Sodium capsules. U. S. v. Gary Drug Co., Inc., Jacob H. Raverby, and Tobias Levine. Pleas of guilty. Fine of $200 against corporation and 50 against each individual.1